NIH-funded research R01 grant

Turning scar-forming support cells into neurons to repair spinal cord injuries

Official title: Converting the glial scar to neurons repairs the injured neural circuits for functional recovery following spinal cord injury

Funded at University of Louisville · NIH-11393167 · Data updated 2026-11-12

This project uses a cell-reprogramming approach to make support cells into new nerve cells to help people with spinal cord injuries regain function.

More Spinal Cord Injury research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startApril 1, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$329,532
NIH project number5R01NS131489-03
Project IDNIH-11393167 on NIH RePORTER

Who could benefit from this research

Could help

Adults who have experienced a spinal cord injury with loss of motor or sensory function could be considered relevant candidates for future clinical steps.

Less likely to help

People without spinal cord injury or whose injuries are incompatible with local reprogramming (for example, damage too extensive or medically unstable) would likely not benefit.

What this research studies

From a patient's perspective, researchers are using a factor called SOX2 to reprogram certain support cells (NG2 glia) in the injured spinal cord into new neurons. They aim to reduce the inhibitory astrocyte scar and encourage axons and surviving neurons to reconnect and transmit signals. The work involves laboratory and preclinical experiments using injured adult spinal cords, advanced 3D imaging, and tests of movement and nerve signaling. The team will measure whether the new neurons integrate into circuits and lead to functional improvements.

Why it matters

Potential benefit: If successful, this approach could restore lost nerve connections and improve movement and sensation after spinal cord injury.

How similar studies have gone: Related SOX2-based reprogramming work has produced new neurons and partial functional recovery in animal models, but it has not yet been proven effective in people.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Researchers

  • Principal investigator: Wu, Wei — University of Louisville
  • Study coordinator: Wu, Wei

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.